搜索筛选:
搜索耗时4.0618秒,为你在为你在102,285,761篇论文里面共找到 6 篇相符的论文内容
发布年度:
Clinical Implementation of a Glycoprotein Biomarker for Estimating the Progression of Liver Fibrosis
[会议论文] 作者：Atsushi Kuno,Hisashi Narimatsu,Yuzuru Ikehara,Maki Sogabe,Dongning Du,Atsushi Matsuda,Jun Hirabayashi,
来源：The 3rd Asian Communications of Glycobiology and Glycotechno 年份：2011
...
Clinical Implementation of a Glycoprotein Biomarker for Estimating the Progression of Liver Fibrosis
[会议论文] 作者：Atsushi Kuno,Hisashi Narimatsu,Yuzuru Ikehara,Yasuhito Tanaka,Maki Sogabe,Dongning Du,Atsushi Matsuda,
来源：The 3rd Asian Communications of Glycobiology and Glycotechno 年份：2011
...
LecT-Hepa facilitates estimating the treatment outcomes during the interferon therapy in chronic hep
[会议论文] 作者：Xia Zou,Wei Li,Yan Zhang,Xiumei Chi,Yu Pan,Haibo Sun,Junqi Niu,Dongning Du,Atsushi Matsuda,Atsushi Kuno,
来源：2014年全国糖生物学学术会议 年份：2014
...
LecT-Hepa facilitates estimating the treatment outcomes during the interferon therapy in chronic hep
[会议论文] 作者：Xia Zou,Xiumei Chi,Yu Pan,Dongning Du,Haibo Sun,Atsushi Matsuda,Wei Li,Atsushi Kuno,Hisashi Narimatsu,
来源：2014年全国糖生物学学术会议 年份：2014
The standard treatment for chronic hepatitis C (CHC) is a combination of interferon and ribavirin.Developing noninvasive tests that can predict treatment outcome at an early stage of therapy is benefi...
[会议论文] 作者：Dongning Du,Hisashi Narimatsu,Yan Zhang,Yuzuru Ikehara,Atsushi Kuno,Atsushi Matsuda,Kozue Saito,Yasuhito,
来源：The 3rd Asian Communications of Glycobiology and Glycotechno 年份：2011
...
[会议论文] 作者：Zhang,Yuzuru Ikehara,Yasuhito Tanaka,Xinxin Zhang,Hisashi Narimatsu,Xuejuan Zhu,Atsushi Kuno,Atsushi Matsuda,
来源：The 3rd Asian Communications of Glycobiology and Glycotechno 年份：2011
...
相关搜索：
